Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C-Reference-Cited by-同舟云学术

Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C

Published:2018-07 Issue:4 Volume:17 Page:569-576
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Attallah Abdelfattah M.,Omrang Dalia,Omran Mohamed M.,Abdelrazek Mohamed A.,Zayed Rania,Essawey Riham El,Saif Sameh,Farid Azza,Hassany Mohamed,Yosry Ayman,Omar Ashraf

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference28 articles.

1. The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C;Domagalski;PLoS One,2015

2. Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis;Noureddin;Hepatol,2013

3. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection;Kitson;J Gastroenterol Hepatol,2014

4. Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection;Marabita;Hepatol,2011

5. Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype;Falleti;J Clin Immunol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy;Journal of Genetic Engineering and Biotechnology;2021-10-08

2. Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population;Archives of Virology;2021-02-02

3. Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapy;Expert Review of Anti-infective Therapy;2020-06-22

4. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis;British Journal of Biomedical Science;2019-05-23